GSK3B and metabolic dysfunction-associated steatotic liver disease: In the progression of non-alcoholic fatty liver disease (NAFLD), overactivation of GSK-3β is a critical molecular node linking lipid metabolic disorders, insulin resistance, hepatic inflammation, and fibrosis.